Effects of female sex hormones on responses to CGRP, acetylcholine, and 5-HT in rat isolated arteries

Headache

Volumn 47, Issue 4, 2007, Pages 564-575

  Gupta, Saurabh ^a   Mehrotra, Suneet ^c   Villalón, Carlos ^b   De Vries, René ^a   Garrelds, Ingrid ^a   Saxena, Pramod ^a   VanDenBrink, Antoinette Maassen ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c Department of Pharmacology ^*

Author keywords

17 estradiol; 5 hydroxytryptamine; Acetylcholine; Calcitonin gene related peptide; Migraine; Rat artery

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLCHOLINE; CALCITONIN GENE RELATED PEPTIDE; ENDOTHELIN 1; ESTRADIOL; PLACEBO; POTASSIUM CHLORIDE; PROGESTERONE; SEROTONIN; SEX HORMONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY DILATATION; ARTICLE; BASILAR ARTERY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; FEMALE; MESENTERIC ARTERY; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT;

ACETYLCHOLINE; ANIMALS; ARTERIES; CALCITONIN GENE-RELATED PEPTIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEMALE; GONADAL STEROID HORMONES; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; VASOCONSTRICTION; VASODILATION;

EID: 34247239822     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2006.00596.x     Document Type: Article

References (64)

1. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: Data from the American Migraine Study II. Headache. 2001;41:646-657.
2. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA. 1992;267:64-69.
3. MacGregor EA, Hackshaw A. Prevalence of migraine on each day of the natural menstrual cycle. Neurology. 2004;63:351-353.
4. Silberstein SD. Headaches in pregnancy. Neurol Clin. 2004;22:727-756.
5. Wang SJ, Fuh JL, Lu SR, Juang KD, Wang PH. Migraine prevalence during menopausal transition. Headache. 2003;43:470-478.
6. Stewart WF, Linet MS, Celentano DD, Van Natta M, Ziegler D. Age- and sex-specific incidence rates of migraine with and without visual aura. Am J Epidemiol. 1991;134:1111-1120.
7. De Vries P, Villalón CM, Saxena PR. Pharmacological aspects of experimental headache models in relation to acute antimigraine therapy. Eur J Pharmacol. 1999;375:61-74.
8. Durham P, Russo A. New insights into the molecular actions of serotonergic antimigraine drugs. Pharmacol Ther. 2002;94:77-92.
9. Edvinsson L. Calcitonin gene-related peptide (CGRP) and the pathophysiology of headache: Therapeutic implications. CNS Drugs. 2001;15:745-753.
10. Arulmani U, Maassen VanDenBrink A, Villalón CM, Saxena PR. Calcitonin gene-related peptide and its role in migraine pathophysiology. Eur J Pharmacol. 2004;500:315-330.
11. Doods H, Hallermayer G, Wu D, et al. Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist. Br J Pharmacol. 2000;129:420-423.
12. Olesen J, Diener HC, Husstedt IW, et al. Calcitonin gene-related peptide receptor antagonist BIBN4096BS for the acute treatment of migraine. N Engl J Med. 2004;350:1104-1110.
13. Saxena PR, Tfelt-Hansen P. Triptans, 5-HT1B/1D receptor agonists in the acute treatment of migraine. In: Olesen J, Goadsby PJ, Ramadan N, Tfelt-Hansen P, Welch KMA, eds. The Headaches. Philadelphia: Lippincott Williams & Wilkins; 2005:469-503.
14. Villalón CM, Centurión D, Valdivia LF, De Vries P, Saxena PR. An introduction to migraine: From ancient treatment to functional pharmacology and antimigraine therapy. Proc West Pharmacol Soc. 2002;45:199-210.
15. Suzuki T, Nakamura Y, Moriya T, Sasano H. Effects of steroid hormones on vascular functions. Microsc Res Tech. 2003;60:76-84.
16. Lau YT. Receptor-dependent and genomicindependent actions of estrogen in vascular protection. Chang Gung Med J. 2002;25:636-644.
17. Nawate S, Fukao M, Sakuma I, et al. Reciprocal changes in endothelium-derived hyperpolarizing factor- and nitric oxide-system in the mesenteric artery of adult female rats following ovariectomy. Br J Pharmacol. 2005;144:178-189.
18. Kelly MJ, Levin ER. Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol Metab. 2001;12:152-156.
19. Gangula PR, Zhao H, Wimalawansa SJ, Supowit SC, DiPette DJ, Yallampalli C. Pregnancy and steroid hormones enhance the systemic and regional hemodynamic effects of calcitonin gene-related peptide in rats. Biol Reprod. 2001;64:1776-1783.
20. Yallampalli C, Gangula PR, Kondapaka S, Fang L, Wimalawansa S. Regulation of calcitonin generelated peptide receptors in the rat uterus during pregnancy and labor and by progesterone. Biol Reprod. 1999;61:1023-1030.
21. Dong YL, Fang L, Kondapaka S, Gangula PR, Wimalawansa SJ, Yallampalli C. Involvement of calcitonin gene-related peptide in the modulation of human myometrial contractility during pregnancy. J Clin Invest. 1999;104:559-565.
22. Ma QL, Zhou HY, Sun M. [Relationship between sex hormone levels and blood calcitonin gene-related peptide/endothelin-1 in postmenopausal women with coronary heart disease]. Hunan Yi Ke Da Xue Xue Bao. 2001;26:146-148.
23. Momoi H, Ikomi F, Ohhashi T. Estrogen-induced augmentation of endothelium-dependent nitric oxide-mediated vasodilation in isolated rat cerebral small arteries. Jpn J Physiol. 2003;53:193-203.
24. Rahimian R, Laher I, Dube G, Van Breemen C. Estrogen and selective estrogen receptor modulator LY117018 enhance release of nitric oxide in rat aorta. J Pharmacol Exp Ther. 1997;283:116-122.
25. Minshall RD, Stanczyk FZ, Miyagawa K, et al. Ovarian steroid protection against coronary artery hyperreactivity in rhesus monkeys. J Clin Endocrinol Metab. 1998;83:649-659.
26. Ma L, Yu Z, Xiao S, Thadani U, Robinson CP, Patterson E. Supersensitivity to serotonin- and histamineinduced arterial contraction following ovariectomy. Eur J Pharmacol. 1998;359:191-200.
27. Minshall RD, Miyagawa K, Chadwick CC, Novy MJ, Hermsmeyer K. In vitro modulation of primate coronary vascular muscle cell reactivity by ovarian steroid hormones. FASEB J. 1998;12:1419-1429.
28. Teoh H, Quan A, Leung SW, Man RY. Differential effects of 17β-estradiol and testosterone on the contractile responses of porcine coronary arteries. Br J Pharmacol. 2000;129:1301-1308.
29. Mugge A, Barton M, Fieguth HG, Riedel M. Contractile responses to histamine, serotonin, and angiotensin II are impaired by 17β-estradiol in human internal mammary arteries in vitro. Pharmacology. 1997;54:162-168.
30. Blacklock AD, Cauveren JA, Smith PG. Estrogen selectively increases sensory nociceptor innervation of arterioles in the female rat. Brain Res. 2004;1018:55-65.
31. Ralevic V. Endothelial nitric oxide modulates perivascular sensory neurotransmission in the rat isolated mesenteric arterial bed. Br J Pharmacol. 2002;137:19-28.
32. 37 antagonizes vasodilations and cAMP responses to rat CGRP in rat caudal artery. Ann N Y Acad Sci. 1992;657:513-515.
33. Nyborg NC, Baandrup U, Mikkelsen EO, Mulvany MJ. Active, passive and myogenic characteristics of isolated rat intramural coronary resistance arteries. Pflügers Arch. 1987;410:664-670.
34. Maassen VanDenBrink A, Van den Broek RWM, De Vries R, Bogers AJJC, Avezaat CJJ, Saxena PR. Craniovascular selectivity of eletriptan and sumatriptan in human isolated blood vessels. Neurology. 2000;55:1524-1530.
35. Foulkes R, Shaw N, Bose C, Hughes B. Differential vasodilator profile of calcitonin gene-related peptide in porcine large and small diameter coronary artery rings. Eur J Pharmacol. 1991;201:143-149.
36. Gangula PR, Lanlua P, Bukoski RD, Wimalawansa SJ, Yallampalli C. Mesenteric arterial relaxation to calcitonin gene-related peptide is increased during pregnancy and by sex steroid hormones. Biol Reprod. 2004;71:1739-1745.
37. Jansen-Olesen I, Jorgensen L, Engel U, Edvinsson L. In-depth characterization of CGRP receptors in human intracranial arteries. Eur J Pharmacol. 2003;481:207-216.
38. Gupta S, Mehrotra S, Villalón CM, et al. Characterisation of CGRP receptors in human and porcine isolated coronary arteries: Evidence for CGRP receptor heterogeneity. Eur J Pharmacol. 2006;530:107-116.
39. Bergdahl A, Valdemarsson S, Nilsson T, Sun XY, Hedner T, Edvinsson L. Dilatory responses to acetylcholine, calcitonin gene-related peptide and substance P in the congestive heart failure rat. Acta Physiol Scand. 1999;165:15-23.
40. + on the tachyphylaxis. Eur J Pharmacol. 1998;351:53-59.
41. Frayon S, Cueille C, Gnidehou S, De Vernejoul MC, Garel JM. Dexamethasone increases RAMP1 and CRLR mRNA expressions in human vascular smoothmuscle cells. Biochem Biophys Res Commun. 2000;270:1063-1067.
42. Moura MJ, Marcondes FK. Influence of estradiol and progesterone on the sensitivity of rat thoracic aorta to noradrenaline. Life Sci. 2001;68:881-888.
43. Cox MW, Fu W, Chai H, et al. Effects of progesterone and estrogen on endothelial dysfunction in porcine coronary arteries. J Surg Res. 2005;124:104-111.
44. Dong YL, Vegiraju S, Gangula PR, Kondapaka SB, Wimalawansa SJ, Yallampalli C. Expression and regulation of calcitonin gene-related peptide receptor in rat placentas. Biol Reprod. 2002;67:1321-1326.
45. Jiang C, Sarrel PM, Poole-Wilson PA, Collins P. Acute effect of 17β-estradiol on rabbit coronary artery contractile responses to endothelin-1. Am J Physiol. 1992;263:H271-H275.
46. Veille JC, Li P, Eisenach JC, MassmannAG,Figueroa JP. Effects of estrogen on nitric oxide biosynthesis and vasorelaxant activity in sheep uterine and renal arteries in vitro. Am J Obstet Gynecol. 1996;174:1043-1049.
47. Dai Z, Zhu HQ, Jiang DJ, Jiang JL, Deng HW, Li YJ. 17β-estradiol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level. Int J Cardiol. 2004;96:223-227.
48. Wanstall JC, Fiore SA, Gambino A, Chess-Williams R. Potentiation of 5-hydroxytryptamine (5-HT) responses by a 5-HT uptake inhibitor in pulmonary and systemic vessels: Effects of exposing rats to hypoxia. Naunyn Schmiedebergs Arch Pharmacol. 2003;368:520-527.
49. Shay J, Futo J, Badrov N, Moss J. Estrogen withdrawal selectively increases serotonin reactivity in rabbit basilar artery. Life Sci. 1994;55:1071-1081.
50. Yallampalli C, Kondapaka SB, Lanlua P, Wimalawansa SJ, Gangula PR. Female sex steroid hormones and pregnancy regulate receptors for calcitonin gene-related peptide in rat mesenteric arteries, but not in aorta. Biol Reprod. 2004;70:1055-1062.
51. Teoh H, Man RY. Enhanced relaxation of porcine coronary arteries after acute exposure to a physiological level of 17β-estradiol involves non-genomic mechanisms and the cyclic AMP cascade. Br J Pharmacol. 2000;129:1739-1747.
52. Martin VT, Behbehani M. Ovarian hormones and migraine headache: Understanding mechanisms and pathogenesis-part I. Headache. 2006;46:3-23.
53. Martinez C, Lopez C, Hidalgo A, Sanchez M, Garcia Be Boto MJ. Gonadectomy eliminates endotheliumdependent diethylstilbestrol-induced relaxant effect in rat aorta. Pharmacology. 2003;67:136-142.
54. Magos AL, Zilkha KJ, Studd JW. Treatment of menstrual migraine by oestradiol implants. J Neurol Neurosurg Psychiatry. 1983;46:1044-1046.
55. Somerville BW. The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology. 1972;22:355-365.
56. Aube M. Migraine in pregnancy. Neurology. 1999;53:S26-S28.
57. Uknis A, Silberstein SD. Review article: Migraine and pregnancy. Headache. 1991;31:372-374.
58. Larsson-Cohn U, Lundberg PO. Headache and treatment with oral contraceptives. Acta Neurol Scand. 1970;46:267-278.
59. Aegidius K, Zwart JA, Hagen K, Schei B, Stovner LJ. Oral contraceptives and increased headache prevalence: The Head-HUNT Study. Neurology. 2006;66:349-353.
60. Cupini LM, Matteis M, Troisi E, Calabresi P,Bernardi G, Silvestrini M. Sex-hormone-related events in migrainous females. A clinical comparative study between migraine with aura and migraine without aura. Cephalalgia. 1995;15:140-144.
61. Massiou H, MacGregor EA. Influence of female hormone on migraines. In: Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA, eds. The Headcahes. Philadelphia: LippincottWilliams & Wilkins; 2006:336.
62. Neri I, Granella F, Nappi R, Manzoni GC, Facchinetti F, Genazzani AR. Characteristics of headache at menopause: A clinico-epidemiologic study. Maturitas. 1993;17:31-37.
63. Pringsheim T, Gooren L. Migraine prevalence in male to female transsexuals on hormone therapy. Neurology. 2004;63:593-594.
64. Welch KMA, Brandes JL, Berman NE. Mismatch in how oestrogen modulates molecular and neuronal function may explain menstrual migraine. Neurol Sci. 2006;27(suppl 2):S190-S192.